Search Results

There are 1862 results for: content related to: Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

  1. You have free access to this content
    Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

    Clinical Cardiology

    Volume 37, Issue 1, January 2014, Pages: 32–47, Irene Savelieva and A. John Camm

    Article first published online : 19 NOV 2013, DOI: 10.1002/clc.22204

  2. You have free access to this content
    Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 2, April 2014, Pages: 118–135, J. W. Cheng and G. Barillari

    Article first published online : 3 JAN 2014, DOI: 10.1111/jcpt.12122

  3. You have free access to this content
    Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 628–636, Y. Lu, R. Branstad, R. M. Karim and R. W. Asinger

    Article first published online : 24 SEP 2014, DOI: 10.1111/jcpt.12207

  4. Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 707–717, Yoon K. Loke, Shiva Pradhan, Jessica Ka-yan Yeong and Chun Shing Kwok

    Article first published online : 19 SEP 2014, DOI: 10.1111/bcp.12376

  5. New Avenues for Anticoagulation in Atrial Fibrillation

    Clinical Pharmacology & Therapeutics

    Volume 93, Issue 1, January 2013, Pages: 68–77, S Mantha, K Cabral and J Ansell

    Article first published online : 5 DEC 2012, DOI: 10.1038/clpt.2012.197

  6. New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation

    Journal of Cardiovascular Electrophysiology

    Volume 22, Issue 8, August 2011, Pages: 948–955, JUAN F. VILES-GONZALEZ, VALENTIN FUSTER and JONATHAN L. HALPERIN

    Article first published online : 10 JUN 2011, DOI: 10.1111/j.1540-8167.2011.02104.x

  7. You have free access to this content
    Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue 8, August 2009, Pages: 1313–1320, P. C. WONG, E. J. CRAIN, C. A. WATSON and B. XIN

    Article first published online : 3 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03503.x

  8. You have free access to this content
    Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives

    European Journal of Haematology

    Antonio Gómez-Outes, Mª Luisa Suárez-Gea, Ramón Lecumberri, Ana Isabel Terleira-Fernández and Emilio Vargas-Castrillón

    Article first published online : 16 JUL 2015, DOI: 10.1111/ejh.12610

  9. You have free access to this content
    Drug and dietary interactions of the new and emerging oral anticoagulants

    International Journal of Clinical Practice

    Volume 64, Issue 7, June 2010, Pages: 956–967, J. M. Walenga and C. Adiguzel

    Article first published online : 17 MAY 2010, DOI: 10.1111/j.1742-1241.2009.02286.x

  10. You have free access to this content
    Implications of new anticoagulants in primary practice

    International Journal of Clinical Practice

    Volume 67, Issue 2, February 2013, Pages: 139–156, A. Perez, L. H. Eraso and G. J. Merli

    Article first published online : 11 JAN 2013, DOI: 10.1111/ijcp.12023

    Corrected by:

    Erratum: Erratum

    Vol. 67, Issue 8, 816, Article first published online: 22 JUL 2013

  11. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Article first published online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  12. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography – tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 10, October 2014, Pages: 1636–1646, E. M. H. Schmitz, K. Boonen, D. J. A. van den Heuvel, J. L. J. van Dongen, M. W. M. Schellings, J. M. A. Emmen, F. van der Graaf, L. Brunsveld and D. van de Kerkhof

    Article first published online : 9 OCT 2014, DOI: 10.1111/jth.12702

  13. You have free access to this content
    Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S100–S107, John W. Eikelboom and Robert G. Hart

    Article first published online : 3 MAR 2012, DOI: 10.1002/ajh.23136

  14. You have free access to this content
    New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation

    Journal of Internal Medicine

    Volume 271, Issue 6, June 2012, Pages: 554–565, A. Tripodi and G. Palareti

    Article first published online : 19 APR 2012, DOI: 10.1111/j.1365-2796.2012.02541.x

  15. You have free access to this content
    Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation

    Journal of Internal Medicine

    Volume 278, Issue 1, July 2015, Pages: 1–18, A. M. Shields and G. Y. H. Lip

    Article first published online : 15 APR 2015, DOI: 10.1111/joim.12360

  16. You have free access to this content
    New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management

    Internal Medicine Journal

    Volume 44, Issue 6, June 2014, Pages: 525–536, H. Tran, J. Joseph, L. Young, S. McRae, J. Curnow, H. Nandurkar, P. Wood and C. McLintock

    Article first published online : 19 JUN 2014, DOI: 10.1111/imj.12448

  17. You have free access to this content
    New anticoagulants – promising and failed developments

    British Journal of Pharmacology

    Volume 165, Issue 2, January 2012, Pages: 363–372, Job Harenberg, Svetlana Marx, Martin Krejczy and Martin Wehling

    Article first published online : 16 DEC 2011, DOI: 10.1111/j.1476-5381.2011.01578.x

  18. You have free access to this content
    Oral Anticoagulants to Reduce the Risk of Stroke in Atrial Fibrillation: How Should a Clinician Choose?

    Clinical Cardiology

    Volume 36, Issue 11, November 2013, Pages: 663–670, Ilyas Mohammed, Wajihuddin Syed and Peter R. Kowey

    Article first published online : 24 JUL 2013, DOI: 10.1002/clc.22173

  19. You have free access to this content
    Implementing the new oral anticoagulants into the hospital formulary

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S127–S132, Michael Palladino, Lynda Thomson, Brian Swift, and Geno J. Merli

    Article first published online : 12 APR 2012, DOI: 10.1002/ajh.23208

  20. Recent Advances in the Development of Specific Antidotes for Target-Specific Oral Anticoagulants

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 2, February 2015, Pages: 198–207, Yoonsun Mo and Felix K. Yam

    Article first published online : 3 FEB 2015, DOI: 10.1002/phar.1532